Search Results
Jan 28, 2026, 09:00 ET Class Action Filed Against Klarna Group plc (KLAR) Seeking Recovery for Investors - Contact Levi & Korsinsky
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET Shareholders that lost money on Coupang, Inc. (CPNG) should contact Levi & Korsinsky about pending Class Action - CPNG
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET Investors in Integer Holdings Corporation Should Contact Levi & Korsinsky Before February 9, 2026 to Discuss Your Rights - ITGR
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 2, 2026 in Blue Owl Capital Inc. Lawsuit - OWL
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET Levi & Korsinsky Notifies Shareholders of Smart Digital Group Limited (SDM) of a Class Action Lawsuit and an Upcoming Deadline
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET Levi & Korsinsky Notifies Ardent Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ARDT
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET FRMI LAWSUIT ALERT: Levi & Korsinsky Notifies Fermi Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected]:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET Class Action Filed Against DeFi Technologies (DEFT) Seeking Recovery for Investors - Contact Levi & Korsinsky
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 9, 2026 in Varonis Lawsuit - VRNS
the top securities litigation firms in the United States.CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 27th FloorNew York, NY [email protected] Tel:
More news about: Levi & Korsinsky, LLP
Jan 28, 2026, 08:50 ET Just in Time for Valentine's Day, BoomRx Launches Oral Liquid Erectile-Dysfunction Therapy
sourcing and fulfillment, today announced the availability of a new oral liquid erectile dysfunction (ED) therapy that combines Viagra, Cialis and Levitra—offered as an alternative to conventional ED formulations currently on the market. Developed to support medical clinics and healthcare providers
More news about: BoomRx
Jan 28, 2026, 08:00 ET Boehringer Ingelheim convenes "Detect the SOS" Collective for public health mission: increase uACR screening among adults with type 2 diabetes and/or high blood pressure to help uncover kidney damage and elevated heart risks
-mission-increase-uacr-screening-among-adults-with-type-2-diabetes-andor-high-blood-pressure-to-help-uncover-kidney-damage-and-elevated-heart-risks-302671935.htmlSOURCE Boehringer Ingelheim
More news about: Boehringer Ingelheim
Jan 28, 2026, 06:49 ET Quando l'innovazione incontra l'atletica: Huawei ed Eliud Kipchoge presentano l'orologio da running di nuova generazione
content:https://www.prnewswire.com/news-releases/quando-linnovazione-incontra-latletica-huawei-ed-eliud-kipchoge-presentano-lorologio-da-running-di-nuova-generazione-302672586.html
More news about: HUAWEI
Jan 28, 2026, 05:02 ET Mouser Electronics bổ sung hơn 60 nhà sản xuất mới vào danh mục phân phối hàng đầu ngành trong năm 2025, mở rộng lựa chọn cho khách hàng
multimedia:https://www.prnewswire.com/vn/news-releases/u006Du006Fu0075u0073u0065u0072u002Du0065u006Cu0065u0063u0074u0072u006Fu006Eu0069u0063u0073u002Du0062u1ED5u002Du0073u0075u006Eu0067u002Du0068-302672473.htmlSOURCE
More news about: Mouser Electronics
Jan 28, 2026, 04:14 ET Компания Skyhawk Therapeutics объявляет промежуточные результаты за девять месяцев среди пациентов клинического исследования фазы 1 препарата SKY-0515 для лечения болезни Гантингтона
cUHDRS от ожидаемого ухудшения при естественном течении болезни согласно предварительным анализам через три, шесть и девять месяцев, — сказал Эд Уайлд (Ed Wild), профессор неврологии в Университетском колледже Лондона. — Препарат SKY-0515 продолжает снижать уровень белка mHTT в большей степени, чем демонстрируют
More news about: Skyhawk Therapeutics
Jan 28, 2026, 03:50 ET Skyhawk Therapeutics、ハンチントン病治療薬SKY-0515の第I相臨床試験における患者の9か月中間結果を発表
ら平均して改善したことが示されました。Enroll-HDとTRACK-HDを用いた傾向スコア重み付けに基づく症状のある患者におけるcUHDRSの9か月時点の予想悪化は-0.73点であるのに対し、本試験の9か月時点のプール解析での改善は+0.64点となりました。ユニバーシティ・カレッジ・ロンドンの神経学教授、Ed Wild氏は、「SKY-0515投与の患者を対象とした第I相パートC試験の安全性データおよび初期有効性データにより、3か月、6か月、9か月時点の事前規定解析において、cUHDRSが自然歴で予想される悪化とは違う結果になることが示され、非常に心強く感じています」と述べました
More news about: Skyhawk Therapeutics
Jan 28, 2026, 03:11 ET Společnost Skyhawk Therapeutics oznamuje průběžné výsledky za devět měsíců u pacientů z 1. fáze klinického hodnocení přípravku SKY-0515 pro léčbu Huntingtonovy choroby
povzbudivé a ukazují odchylku cUHDRS od očekávaného zhoršení přirozeného vývoje ve třech, šesti a devíti měsících předem specifikovaných analýz," řekl Ed Wild, profesor neurologie na University College London. „Přípravek SKY-0515 nadále snižuje hladinu proteinu mHTT v největší míře, jaká byla dosud u pacientů
More news about: Skyhawk Therapeutics
Jan 27, 2026, 22:10 ET Spoločnosť Skyhawk Therapeutics oznamuje predbežné výsledky u pacientov z fázy 1 klinického skúšania lieku SKY-0515 za deväť mesiacov liečby Huntingtonovej choroby
odchýlku v cUHDRS od očakávaného zhoršenia prirodzeného priebehu vo vopred špecifikovaných analýzach po troch, šiestich a deviatich mesiacoch," povedal Ed Wild, profesor neurológie na University College London. „Liek SKY-0515 naďalej znižuje hladinu mHTT proteínu v najväčšej miere, akú doteraz preukázala
More news about: Skyhawk Therapeutics
Jan 27, 2026, 16:36 ET CON EDISON DECLARES COMMON STOCK DIVIDEND
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) (NYSE: ED) declared a quarterly dividend of 88.75 cents a share on its common stock, payable March 16, 2026 to stockholders of record as of February 18, 2026, an
More news about: Consolidated Edison, Inc.
Jan 27, 2026, 10:49 ET Xây dựng nền tảng cốt lõi cho sản xuất điện mặt trời thông minh: Khu Công nghiệp Điện mặt trời thông minh SKYWORTH đạt mốc cất nóc kết cấu chính
content:https://www.prnewswire.com/vn/news-releases/u0078u0061u0079u002Du0064u1EF1u006Eu0067u002Du006Eu1EC1u006Eu002Du0074u1EA3u006Eu0067u002Du0063u1ED1u0074u002Du006Cu006Fu0069u002Du0063u0068-302671412.htmlSOURCE
More news about: SKYWORTH PV
Jan 27, 2026, 10:22 ET Skyhawk Therapeutics Công Bố Kết Quả Nghiên Cứu Tạm Thời trên Bệnh Nhân sau 9 Tháng tiến hành Thử Nghiệm Lâm Sàng Giai Đoạn 1 thuốc SKY-0515 để Điều Trị bệnh Huntington
chuyển biến ngày càng xấu đi theo diễn biến bệnh tự nhiên tại các mốc phân tích được xác định trước ở tháng thứ 3, thứ 6 và thứ 9", Giáo Sư Thần Kinh Học Ed Wild tại Đại Học College London cho biết. "SKY-0515 đang là loại thuốc có khả năng làm giảm protein mHTT mạnh nhất so với bất kỳ liệu pháp nào từng được
More news about: Skyhawk Therapeutics
Jan 27, 2026, 10:18 ET SPH Consulting Group Shares a Guide to Leading Higher Ed Mergers & Closures in Today's Challenging Environment
Jan. 27, 2026 /PRNewswire/ -- In an era of unprecedented disruption for higher education, Leading Existential Change in Higher Ed emerges as an essential resource for university presidents, chancellors, trustees, and board members seeking to navigate the complexities of mergers,
More news about: SPH Consulting Group
Jan 27, 2026, 09:40 ET Skyhawk Therapeutics ogłasza dziewięciomiesięczne wyniki pośrednie badań klinicznych fazy 1 nad lekiem SKY-0515 stosowanym w leczeniu choroby Huntingtona
przebiegu choroby po trzech, sześciu i dziewięciu miesiącach od rozpoczęcia badania, zgodnie z wcześniej ustalonym harmonogramem analiz - powiedział Ed Wild, profesor neurologii na University College London. - SKY-0515 nadal redukuje białko mHTT w największym stopniu spośród wszystkich dotychczas testowanych
More news about: Skyhawk Therapeutics
Jan 27, 2026, 09:37 ET Skyhawk Therapeutics anuncia resultados de su ensayo clínico de SKY-0515 para la enfermedad de Huntington
divergencia en la cUHDRS que se aleja del deterioro esperado de la historia natural en los análisis preespecificados a los tres, seis y nueve meses", afirmó Ed Wild, profesor de Neurología del University College de Londres. "SKY-0515 continúa reduciendo la proteína mHTT en la mayor medida demostrada por cualquier
More news about: Skyhawk Therapeutics
Jan 27, 2026, 09:00 ET On The Go Appoints Matt King as Chief Executive Officer
experience, and delivering financial performance across complex, distributed businesses."Matt is the right leader for On The Go at this moment," said Ed Sirhal, Chair of People & Talent Committee of On The Go. "He brings a rare combination of industry insight, sound judgment, and a people-first leadership
More news about: OTG Management
Jan 27, 2026, 09:00 ET Healthgrades Names Mount Sinai Medical Center One of America's 100 Best Hospitals
nationwide."This honor reflects the everyday work of extraordinary teams," said Gino R. Santorio, President and CEO of Mount Sinai Medical Center. "From the ED to the ICU to our specialty programs, our physicians, nurses, and staff are aligned on one standard—exceptional outcomes and compassionate care for the
More news about: Mount Sinai Medical Center